COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    Trifecta Durability
Previous Study | Return to List | Next Study

Trifecta Durability Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01256710
Recruitment Status : Active, not recruiting
First Posted : December 8, 2010
Last Update Posted : February 18, 2020
Information provided by (Responsible Party):
Abbott Medical Devices

Brief Summary:
The purpose of the SJM International, Inc. sponsored "Trifecta™ Durability Study", is to evaluate the long-term durability of the Trifecta™ valve.

Condition or disease Intervention/treatment
Aortic Valve Disorder Device: Implantation of the Trifecta Valve

Layout table for study information
Study Type : Observational
Actual Enrollment : 1231 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Trifecta Durability Study
Study Start Date : January 2011
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021

Group/Cohort Intervention/treatment
Trifecta Valve Group Device: Implantation of the Trifecta Valve
Implantation of the bioprothesis valve, Trifecta Valve

Primary Outcome Measures :
  1. Actuarial freedom from reoperation due to Structural Valve Deterioration [ Time Frame: 10 years ]

Secondary Outcome Measures :
  1. Actuarial survival rate [ Time Frame: 10 years ]
  2. Freedom from valve related death [ Time Frame: 10 years ]
  3. Freedom from structural valve deterioration [ Time Frame: 10 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients that are candicate for implantation or have been implanted over the past 9 months with a St. Jude Medical Trifecta heart valve.

Inclusion Criteria:

  • Patients implanted for less than 9 months, or candidate for implantation with a St Jude Medical Trifecta valve, as per current guidelines
  • Patient requires aortic valve replacement.
  • Patient is legal age in host country.
  • Patients must be able and willing to provide written informed consent to participate in this investigation
  • Patients must be willing and able to comply with all follow-up requirements

Exclusion Criteria:

  • Patients with contraindication for cardiac surgery
  • Patients who are pregnant.
  • Patient is unwilling to or has an inability that reduces his mobility in order to attend the required follow-up visits.
  • Patient has active endocarditis
  • Patient has had an acute preoperative neurological event defined as patient has not returned to baseline 30 days prior to the planned valve implantation surgery.
  • Patient is undergoing renal dialysis.
  • Patient has a documented history of substance abuse within one year of enrollment or is currently a prison inmate.
  • Patient has a documented thrombus in left atrium or left ventricle.
  • Patient had in the past mitral or tricuspid valve replacement.
  • Patient needs mitral and/or tricuspid valve replacement.
  • Patient has an Ejection Fraction < 25%
  • Patient had the Trifecta™ valve implanted as part of this study, but then had the device explanted
  • Preoperative evaluation indicates other significant cardiovascular abnormalities such as aortic dissection or ventricular aneurysm.
  • Patient has a life expectancy less than two years.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01256710

Layout table for location information
Universitat Herzzentrum Leipzig
Leipzig, Germany, 04289
Sponsors and Collaborators
Abbott Medical Devices
Layout table for investigator information
Principal Investigator: Sven Lehmann Universitat Herzzentrum Leipzig
Layout table for additonal information
Responsible Party: Abbott Medical Devices Identifier: NCT01256710    
Other Study ID Numbers: CS-10-012-EU-TV
First Posted: December 8, 2010    Key Record Dates
Last Update Posted: February 18, 2020
Last Verified: February 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No